| Serial Number | 97312900 |
| Word Mark | ANGITIA |
| Filing Date | Tuesday, March 15, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 20, 2024 |
| Registration Number | 7477551 |
| Registration Date | Tuesday, August 20, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 4, 2024 |
| Translation of Words in Mark | The wording angitia has no meaning in a foreign language. |
| Goods and Services | Chemical research; Chemical research services; Computer programming; Computer programming in the medical field; Computer programming services; Design and development of multimedia products; Design services for packaging; Drug discovery services; Drug screening for scientific research purposes; Medical research; Medical research services in the field of cancer; Medical research services; Quality control for others; Quality control of services; Quality control of goods and services; Research and development of new products for others; Research and development services in connection with physics; Scientific investigations for medical purposes; Technological research in the field of manufacturing processes |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 21, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Angitia Biopharmaceuticals Guangzhou Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Guangzhou, Guangdong 510530 CN |
| Party Name | Angitia Biopharmaceuticals Guangzhou Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Guangzhou, Guangdong 510530 CN |
| Party Name | Angitia Biopharmaceuticals Guangzhou Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Guangzhou, Guangdong 510530 CN |
| Event Date | Event Description |
| Tuesday, December 27, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, March 18, 2022 | NEW APPLICATION ENTERED |
| Monday, March 21, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, December 27, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, January 11, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 31, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 31, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 28, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Saturday, September 23, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, March 27, 2024 | TEAS PETITION TO AMEND BASIS RECEIVED |
| Thursday, March 28, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, March 28, 2024 | SOU EXTENSION 2 FILED |
| Thursday, March 28, 2024 | SOU EXTENSION 2 GRANTED |
| Friday, March 29, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, April 22, 2024 | ASSIGNED TO PETITION STAFF |
| Thursday, September 21, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, September 21, 2023 | SOU EXTENSION 1 FILED |
| Thursday, September 21, 2023 | SOU EXTENSION 1 GRANTED |
| Wednesday, May 15, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 4, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 4, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 20, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 20, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, April 23, 2024 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
| Tuesday, April 23, 2024 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Monday, April 29, 2024 | NOTICE OF ALLOWANCE CANCELLED |
| Monday, April 29, 2024 | CASE RETURNED TO EXAMINATION |